心脏全移植血管病变:专注于诊断和管理方面的进展
Colin T Stomberski1, Monica M Colvin1
1University of Michigan, Ann Arbor, Michigan, US.
Methodist DeBakey cardiovascular journal
|May 19, 2025
概括
心脏异体移植血管病 (CAV) 是心脏移植接受者的冠状动脉疾病,源于慢性排斥. 图像学方面的进步有助于早期检测和治疗优化,以保持移植功能.
科学领域:
- 心血管医学 心血管医学
- 移植免疫学 移植免疫学
- 医疗成像医学成像
背景情况:
- 心脏全移植血管病变 (CAV) 是一种特定形式的冠状动脉疾病,影响心脏移植接受者.
- 它是移植后长期发病和死亡的主要原因,通常与慢性排斥有关.
- 免疫和非免疫因素都推动了CAV,导致内脏变厚,纤维化和移植失败.
研究的目的:
- 突出心脏移植中的心脏全移植血管病变 (CAV) 的重要性.
- 讨论最近的成像技术进步在CAV早期检测中的作用.
- 探索改进检测的潜力,以优化CAV向治疗和保护移植功能.
主要方法:
- 审查CAV检测成像方式的近期进展.
- 包括两种侵袭性冠心内成像技术.
- 包括非侵入性成像,特别是心脏正子发射断层扫描.
主要成果:
- 先进的成像模式提高了CAV的早期检测能力.
- 这些改进的检测方法为及时干预提供了潜力.
- 以早期检测为指导的优化疗法可能会减少CAV的进展.
结论:
- 通过先进的成像技术早期发现CAV对于心脏移植接受者至关重要.
- 优化基于早期检测的CAV向疗法可以改善结果.
- 保持移植功能和降低长期死亡率是管理CAV的关键目标.
相关概念视频
Aortic Regurgitation III: Medical Management
598
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
598
Cardiomyopathy I: Introduction and Classification
826
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
826
Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy V: Interprofessional Care
753
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Cardiomyopathy VI: Nursing Management
481
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
481
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
764
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
764


